Clinical Trial Update: Extent of Central Lymph Node Dissection in Papillary Thyroid Microcarcinoma [Phase 2, Phase 3]

View source ↗

Summary

This document provides a clinical trial update on the extent of central lymph node dissection in papillary thyroid microcarcinoma, spanning Phase 2 and Phase 3 …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Papillary Thyroid Carcinoma
• Papillary Thyroid Microcarcinoma

Snippet

Sponsor: Samsung Medical Center | Conditions: Carcinoma | Phase 2, Phase 3 | Status: UNKNOWN